Login
Companies $NVST
$24.03 +$0.00 (0.0%) After hours
Envista Holdings Corp logo

Envista Holdings Corp

envistaco.com

What Do They Do?

Sells dental implant systems and orthodontic products to dental professionals.

How Do They Make Money?

Envista sells equipment, consumables and spare parts, with product sales tied to shipment; customers often pay in advance, while extended warranty and service income is spread over the arrangement term.

revenue
SegmentShareRevenue
Specialty Products & Technologies
Mix

64%
FY2022: 62%
Equipment & Consumables
Mix

36%
FY2022: 38%

Who Are Their Customers?

Dental specialists, general dentists, dental laboratories and dental service organizations buy Envista's products; Specialty Products & Technologies is typically sold directly, while Equipment & Consumables mainly goes through channel partners.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2023: 10% from one customer

Do Revenues Turn Into Profits?

Yes. It kept 2 cents of every revenue dollar as net income in FY2025 and turned 8 cents into free cash flow.

Operating income, FY2025
8% of revenue
▲ Turned profitable vs FY2024 (−$1B, −41%)
Net income, FY2025
2% of revenue
▲ Turned profitable vs FY2024 (−$1.1B, −45%)
Free cash flow, FY2025
8% of revenue
▼ −24% vs FY2024 ($302.7M, 12%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Oct 2, 2026
Revenue
▲ +3%
vs $669.9M in Q3 FY2025
Net income
▲ Turned profitable
vs −$30.3M in Q3 FY2025
Specialty Products & Technologies share of revenue vs 64.4% in Q3 FY2025
  • Aug 19, 2026 CEO Paul Keel becomes Chair of the Board Scott Huennekens continues as a director and becomes Lead Independent Director.
  • Aug 5, 2026 Raises full-year growth and earnings guidance The company lifted ranges for core sales growth, adjusted EBITDA growth and adjusted diluted earnings per share.

Growing. Revenue grew 8% in 4 years, from $2.5B in FY2021 to $2.7B in FY2025, about 2% a year.

Intraoral scanner line Envista has expanded its intraoral scanner portfolio with DEXIS Imprevo; previously, it acquired a scanner business and software portfolio.

Revenue over time
Specialty Products & Technologies Equipment & Consumables
$5B$2.5B$0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support